AFib Risk Check: Discover Your Chances Now with our Easy Survey!

Welcome to the AFib-Risk assessment, a tool that estimates your chances of having atrial fibrillation (AFib). AFib is a common heart rhythm disorder linked to serious complications like stroke. This risk score helps healthcare professionals tailor screening and preventive measures for you. Detecting AFib early allows for personalized treatment, reducing associated risks.

Factors considered in the risk score include age, gender, family history, high blood pressure, diabetes, obesity, smoking, and other medical conditions. The collective evaluation provides a comprehensive AFib likelihood assessment.

Please note that this risk score is not a definitive diagnosis, but a screening tool. Unanswered questions or unknown factors may affect its accuracy. A low-risk score suggests a lower chance of AFib, but does not guarantee zero risk. Seek medical advice for concerns.

A medium/high-risk score indicates increased AFib likelihood, requiring further evaluation and guidance. Early detection and intervention improve outcomes and reduce complications.

Remember, this assessment provides general information and not medical advice. Consult a healthcare professional for personalized evaluation and guidance.

By continuing, you acknowledge the information provided. Let's proceed with the risk assessment.

How old are you?

Let's Calculate Your Body Mass Index (BMI)! To determine your BMI, we need to gather some information. Please provide the following details:

How would you describe your gender?

Which of the following best describes you?

Have you ever experienced or currently experiencing any of the following symptoms? (Please check all that apply)

Have you ever been diagnosed with any heart conditions, taken medications for them, or undergone any heart surgeries? (Please check all that apply)

Have you ever been diagnosed with any of the following medical conditions or currently taking any medications for them?

Are you currently using tobacco products? Please select one of the following options.

How frequently do you consume alcohol? Please select the option that best applies to you:

Does anyone in your immediate family (parents or siblings) have a diagnosis of atrial fibrillation (AFib)?

Do you currently use marijuana or any other cannabinoid products?

Your estimated likelihood of having AFib is

If you're interested in learning more about the factors that can increase your risk of developing AFib, we invite you to explore our AFib-Risk library. By educating yourself about these factors, you can make informed decisions about your heart health. Here are some of the valuable topics you'll find in our library:

• Age: Learn how advancing age can influence your risk of AFib and what steps you can take to mitigate it.
• Medical Conditions: Explore the connection between high blood pressure, diabetes, obesity, and other conditions and their impact on AFib.
• Lifestyle Choices: Understand how smoking, excessive alcohol consumption, and illicit drug use can contribute to the development of AFib.
• Family History: Uncover the role that your family's medical history plays in determining your own susceptibility to AFib.
• Other Risk Factors: Delve into lesser-known factors that can influence AFib risk, such as sleep apnea, thyroid issues, and certain medications.

Comprehensive personalized AFib-Risk assessment and Screening consultation with Dr. Alireza Nazeri.

AFib-Risk Library
References
Home

References:

1. Schnabel RB, Pecen L, Ojeda FM, et al. (2019). "Atrial fibrillation in young adults: Risk factors and clinical implications." International Journal of Cardiology.
2. Alonso A, Krijthe BP, Aspelund T, et al. (2013). "Atrial fibrillation in middle-aged adults: A cause for concern?" Circulation.
3. Gallagher C, Hendriks JM, Mahajan R, et al. (2019). "Atrial fibrillation in the elderly: Risk factors and optimal management." Drugs & Aging.
4. January CT, Wann LS, Alpert JS, et al. (2019). "The changing face of atrial fibrillation: Implications for primary care." Mayo Clinic Proceedings.
5. Thomas MC, Dublin S (2020). "Obesity and atrial fibrillation: A contemporary review." Journal of the American Heart Association.
6. von Euler M, Rosengren A, et al. (2020). "Body mass index and risk of atrial fibrillation: A nationwide study of 1.5 million young Swedish men." Circulation.
7. Abed HS, Wittert GA (2021). "Obesity and atrial fibrillation: Mechanisms and clinical implications." Expert Review of Cardiovascular Therapy.
8. Tadic M, Cuspidi C, Grassi G, et al. (2020). "Ethnic Differences in the Incidence of Atrial Fibrillation: A Systematic Review and Meta-analysis." American Journal of Medicine.
9. Trivedi AN, Helkar AS, Virani SS. (2020). "Racial and Ethnic Differences in the Prevalence, Management, and Outcomes of Atrial Fibrillation: A Systematic Review." Heart Rhythm.
10. Han FT, Zimetbaum P, Marrouche NF, et al. (2019). "Ethnic Differences in Atrial Fibrillation Management and Outcomes in an Academic Medical Center." Journal of the American Heart Association.
11. Walfridsson U, Walfridsson H. (2020). "Symptoms and Functional Status of Patients With Atrial Fibrillation: State of the Art and Future Research Opportunities." Current Heart Failure Reports.
12. Lau DH, Linz D, Sanders P. (2017). "Silent Atrial Fibrillation: Definitions, Detection, and Clinical Significance." Journal of the American College of Cardiology.
13. Gladstone DJ, Bui E, Fang J, et al. (2019). "Asymptomatic Atrial Fibrillation: Clinical Correlates, Management, and Outcomes in the EMBRACE Trial." Journal of the American College of Cardiology.
14. Pathak RK, Middeldorp ME, Meredith M, et al. (2015). "Long-Term Effect of Goal-Directed Weight Management in an Atrial Fibrillation Cohort: A Long-Term Follow-Up Study (LEGACY)." J Am Coll Cardiol.
15. Conen D, Chae CU, Glynn RJ, et al. (2011). "Risk of Death and Cardiovascular Events in Initially Healthy Women With New-Onset Atrial Fibrillation." JAMA.
16. Alonso A, Agarwal SK, Soliman EZ, et al. (2009). "Incidence of Atrial Fibrillation in Whites and African-Americans: The Atherosclerosis Risk in Communities (ARIC) Study." Am Heart J.
17. Huxley RR, Lopez FL, Folsom AR, et al. (2011). "Absolute and Attributable Risks of Atrial Fibrillation in Relation to Optimal and Borderline Risk Factors: The Atherosclerosis Risk in Communities (ARIC) Study." Circulation.
18. Voskoboinik A, Prabhu S, Ling LH, et al. (2016). "Alcohol and Atrial Fibrillation: A Sobering Review." J Am Coll Cardiol.
19. Conen D, Tedrow UB, Cook NR, et al. (2018). "Alcohol Consumption and Risk of Incident Atrial Fibrillation in Women." JAMA Cardiol.
20. Larsson SC, Drca N, Jensen-Urstad M, et al. (2014). "Alcohol Consumption and Risk of Atrial Fibrillation: A Prospective Study and Dose-Response Meta-analysis." J Am Coll Cardiol.
21. Djoussé L, Levy D, Benjamin EJ, et al. (2004). "Long-Term Alcohol Consumption and the Risk of Atrial Fibrillation in the Framingham Study." Am J Cardiol.
22. Lubitz SA, Yin X, Lin H, et al. (2014). "Longitudinal analysis of AF risk in individuals with a family history of atrial fibrillation." Circulation.
23. Christophersen IE, Rienstra M, Roselli C, et al. (2017). "Large-scale analyses of common and rare variants identify 12 new loci associated with atrial fibrillation." Nat Genet.
24. Mahida S, Lubitz SA, Rienstra M. (2017). "Genetics of Atrial Fibrillation." Curr Cardiol Rep.
25. Nielsen JB, Thorolfsdottir RB, Fritsche LG, et al. (2018). "Biobank-driven genomic discovery yields new insight into atrial fibrillation biology." Nat Genet.
26. Arking DE, Chugh SS, Chakravarti A, et al. (2014). "Genetic association study of QT interval highlights role for calcium signaling pathways in myocardial repolarization." Nat Genet.
27. Thomas G, et al. (2020). "Cannabis, Cannabinoids, and Atrial Fibrillation: A Review of the Literature." Frontiers in Cardiovascular Medicine.
28. Chatterjee NA, et al. (2020). "Association Between Marijuana Use and Risk of Cancer: A Systematic Review and Meta-analysis." JAMA Network Open.
29. Jankowski M, et al. (2020). "Cannabis-related stroke: myth or reality? A systematic review of the literature." Current Atherosclerosis Reports.
30. Lippi G, et al. (2020). "Atrial fibrillation and cancer: A systematic review and meta-analysis." The American Journal of Medicine.
31. MacIsaac D, et al. (2016). "Atrial Fibrillation in Athletes." Journal of the American College of Cardiology.
32. Chatterjee NA, et al. (2019). "Association between hypertension and atrial fibrillation: a systematic review and meta-analysis." Heart.
33. Soliman EZ, et al. (2017). "Effect of Intensive Blood Pressure Lowering on Left Ventricular Hypertrophy in Patients with Hypertension: SPRINT (Systolic Blood Pressure Intervention Trial)." Circulation.
34. Tadic M, et al. (2017). "Hypertension and Atrial Fibrillation: From Pathophysiology to Clinical Practice." International Journal of Cardiology.
35. Schnabel RB, et al. (2015). "50 year trends in atrial fibrillation prevalence, incidence, risk factors, and mortality in the Framingham Heart Study: a cohort study." The Lancet.
36. Guzik P, et al. (2017). "The association between hypertension and atrial fibrillation: a systematic review and meta-analysis." Kardiologia Polska.
37. Reddy YNV, et al. (2019). "Atrial Fibrillation and Heart Failure—Cause or Effect?" Heart Failure Clinics.
38. Ponikowski P, et al. (2016). "2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure." European Journal of Heart Failure.
39. Wang TJ. (2018). "The Epidemiology of Heart Failure." In: Gheorghiade M, Filippatos G, eds. Acute Heart Failure: Epidemiology, Diagnosis and Treatment. Springer, Cham.
40. Pandey A, et al. (2019). "Association of Atrial Fibrillation with Mortality and Disability After Ischemic Stroke." Neurology.
41. Freedman B, et al. (2016). "Atrial Fibrillation and Stroke Prevention in Aging Patients." European Heart Journal.
42. AlTurki A, et al. (2018). "The prevalence and impact of atrial fibrillation in patients with chronic coronary artery disease." Journal of Saudi Heart Association.
43. Andrade J, et al. (2019). "Atrial fibrillation and coronary artery disease: a review." Journal of Atrial Fibrillation.
44. Healey JS, et al. (2012). "Subclinical atrial fibrillation and the risk of stroke." New England Journal of Medicine.
45. Kannel WB, et al. (2014). "Atrial fibrillation and risk of cardiovascular disease: the Framingham Study." Journal of the American Heart Association.
46. Nishiyama N, et al. (2018). "Atrial fibrillation in patients with myocardial infarction: a systematic review." Journal of Atrial Fibrillation.
47. Chen S, Chen X, Hou X, et al. (2021). "Early postoperative beta-blockers for preventing atrial fibrillation after cardiac surgery: A systematic review and meta-analysis." J Cardiothorac Vasc Anesth.
48. Deo SV, Shah IK, Dunlay SM, et al. (2020). "Prevalence and clinical characteristics of postoperative atrial fibrillation after cardiac surgery: A national Veterans Affairs study." J Thorac Cardiovasc Surg.
49. Cleveland Clinic. (2020). "Atrial Fibrillation After Heart Surgery." Retrieved from https://my.clevelandclinic.org/health/diseases/16759-atrial-fibrillation-after-heart-surgery
50. American Heart Association. (2021). "What Is Atrial Fibrillation (AFib or AF)?" Retrieved from https://www.heart.org/en/health-topics/atrial-fibrillation/what-is-atrial-fibrillation-afib-or-af
51. National Heart, Lung, and Blood Institute. (2020). "What Is Atrial Fibrillation?" Retrieved from https://www.nhlbi.nih.gov/health-topics/atrial-fibrillation
52. Fang MC, et al. (2019). "Atrial fibrillation in heart valve disease: what should we do?" Journal of the American Heart Association.
53. Haldar S, et al. (2019). "Atrial fibrillation in patients with valvular heart disease: a contemporary review." Europace

Comprehensive personalized AFib-Risk assessment and Screening consultation with Dr. Alireza Nazeri.

AFib-Risk Library